Precision Oncology Highlights From ESMO 2018

Dec

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

Dec

Featured Webinar

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.

Jan

Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Menu

Precision Oncology Highlights From ESMO 2018

To read the full story....

Breaking News

FDA Issues Draft Guidance for Pediatric Studies of Molecularly Targeted Oncology Drugs

Seattle Genetics Presents Positive Tucatinib Phase II Data for HER2-Positive Breast Cancer

Molecular Subgroup May Benefit From Less Toxic CDK4/6 Treatment in ER+ Neoadjuvant Setting

Eli Lilly Opens Phase III Trial for RET Fusion-Positive Non-Small Cell Lung Cancer Drug

Novel HER2 Antibody-Drug Conjugate Shows Promise in Heavily Pretreated Breast Cancer Patients

Benefit Holds Up for Dual Adjuvant HER2 Treatment in Updated Trial Results

Featured White Papers

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

What's Popular?

ACMG Suggests Docs Evaluate All Breast Cancer Patients for Genetic Risk Test Suitability

Universal Genetic Testing in Breast Cancer May Result in More Harm Than Good, Experts Worry

New Data Emerges for Liquid Biopsy in Breast Cancer Residual Disease Detection

Immunotherapy Regimens Yield Contrasting Results in Early Triple Negative Breast Cancer

FDA Issues Draft Guidance for Pediatric Studies of Molecularly Targeted Oncology Drugs

Sponsorships